Key Performance Indicators, Centre Reports, and more Stephen McDonald.

Slides:



Advertisements
Similar presentations
Quality control tools
Advertisements

If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
Topic 12 – Further Topics in ANOVA
© Crown copyright Met Office Towards an optimized communication of probabilistic weather forecasts via the internet Liz Stephens 1, Ken Mylne and David.
Stephen McDonald Philip Clayton Blair Grace Jeremy Chapman Jenni Wright Data From ANZDATA and the Australian National Organ Matching Scheme CHAPTER 7 TRANSPLANT.
Finnish Registry of Kidney Disease, FRKD Quality Registries Meeting Stockholm, December 8th-9th, 2014 presented by: Carola Grönhagen-Riska (chair of the.
What is Forecasting? A forecast is an estimate of what is likely to happen in the future. Forecasts are concerned with determining what the future will.
Marakas: Decision Support Systems, 2nd Edition © 2003, Prentice-Hall Chapter Chapter 4: Modeling Decision Processes Decision Support Systems in the.
Part II – TIME SERIES ANALYSIS C2 Simple Time Series Methods & Moving Averages © Angel A. Juan & Carles Serrat - UPC 2007/2008.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
EVIDENCE BASED MEDICINE
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Opportunity Engineering Harry Larsen The Boeing Company SCEA 2000 Conference.
Chapter 11 Standard costs for control: flexible budgets and manufacturing overhead.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
BENEFIT-OF-THE-DOUBT APPROACHES FOR CALCULATING A COMPOSITE MEASURE OF QUALITY By Michael Shwartz, James F. Burgess, Jr. (Presenting), and Dan Berlowitz.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
Using Probability and Discrete Probability Distributions
Applying of risk-adjusted CUSUM control chart monitoring of medical information Zi-Hsuan Chen Advisor: Jing-Er Chiu, Ph.D.
Discrete Distributions The values generated for a random variable must be from a finite distinct set of individual values. For example, based on past observations,
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Monthly Marketing Report Your Name Today’s Date. Agenda Month highlights Performance measures New trends and developments Threats and opportunities Adjustments.
UKRR Dataset v4.1 How does it fit with the UKRDC ACTIONS IN YOUR RENAL UNIT TO IMPLEMENT THE NEW DATASET UK RENAL REGISTRY 2015 INFORMATICS MEETING: DATA.
Various topics Petter Mostad Overview Epidemiology Study types / data types Econometrics Time series data More about sampling –Estimation.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
Tony Panzarella Princess Margaret Hospital / University of Toronto.
CJT 765: Structural Equation Modeling Class 12: Wrap Up: Latent Growth Models, Pitfalls, Critique and Future Directions for SEM.
Quality & Safety Markers Local process and outcome results presented Falls, Hand hygiene, Peri-operative harm CLAB is not presented as already substantial.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
ANZDATA Session, ANZSN 2015 Matthew JoseStock, flow and direction Kevan Polkinghorne Dialysis modality and survival Namrata Khanal Indigenous transplantation.
Strategic Plan Development Using KPIs to Develop the Strategic Plan.
Gaussian Processes Li An Li An
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
Clerical & Support Staff Introduction to Moving ON Audits & Clinical Indicators.
1 1 Slide Simulation Professor Ahmadi. 2 2 Slide Simulation Chapter Outline n Computer Simulation n Simulation Modeling n Random Variables and Pseudo-Random.
UK Renal Registry 14th Annual Report Figure Consort diagram detailing incident RRT patients 2002–2006, HES admissions and ONS records included in.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Medical Technology and Practice Patterns Institute 4733 Bethesda Ave., Suite #510 Bethesda, MD Phone: Fax: Comparison of.
F5 Performance Management. 2 Section C: Budgeting Designed to give you knowledge and application of: C1. Objectives C2. Budgetary systems C3. Types of.
Copyright  2007 McGraw-Hill Pty Ltd PPTs t/a Marketing Research 2e by Lukas, Hair, Bush and Ortinau Slides prepared by Judy Rex 19-1 Chapter Nineteen.
CPH Dr. Charnigo Chap. 11 Notes Figure 11.2 provides a diagram which shows, at a glance, what a neural network does. Inputs X 1, X 2,.., X P are.
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
ANZDATA Epidemiology Fellow
When Using DOPPS Slides
Developing an early warning system combined with dynamic LMS data
First-year death rates by modality figure 8
Is Hospital Procedure Volume a Reliable Marker of Quality for Coronary Artery Bypass Surgery? A Comparison of Risk and Propensity Adjusted Operative and.
UK Renal Registry 18th Annual Report
CHAPTER 3 Death and Survival on Dialysis
Renal transplantation at Royal Wolverhampton Hospitals Trust
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Selecting the Right Predictors
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
Does equal care give equal outcomes?
Update from the Haemodialysis Working Group
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Dialysis outcomes in Australia & New Zealand
A suite of community-contributed programs to produce outcome tables and graphs for demographic and survival data Not theory-heavy, Stata-heavy or anything.
Demographic Characteristics of Cohort
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

Key Performance Indicators, Centre Reports, and more Stephen McDonald

Barbecue talk

More “good” news

Indigenous incidence rates

Background A number of ongoing work themes exist within ANZDATA for generating output –Stock and flow figures –Annual Report –Contributor requests Responses to information needed for various projects –Research projects (internal and external analyses) –Outcomes reporting

Outcomes reporting Recent years have seen a growth of interest in outcomes reporting Centre reports have been part of ANZDATA for many years, with increasing emphasis in recent years –At “parent hospital level” –Limited distribution historically

Why measure outcomes?

Dialysis outcome

Variation in transplant outcomes

What is happening to centre reports? Greater reporting of demographics and comorbidities Adjusted analyses in transplanting centre and dialysis reports –Details of models supplied Graphs –Funnel plots –CUSUM plots (transplant)

Centre reports – graph 1

Centre reports – graph 2

But....

Adjusted graphs

How are reports derived?

You need a model Logistic regression model (transplant), Poisson model (dialysis) Adjusted for demographics, comorbidities (donor and XM variables) With this model, derive a probability of “expected” failure for each person / graft based on covariate matrix Compare this with actual outcomes

Which predictors are important? Predictive power of multivariate Cox model predicting graft survival, all DD transplants , with sequential addition of covariate groups

Factors within the control of centre –These may be why a particular centre gets good or bad results Factors that occur as a result of treatment decisions For example, don’t adjust for –Choice of dialysis modality, HD access –Use of immunosuppressives, rejection, 1 month graft function… Don’t adjust for…

Other graphical demonstrations of output Funnel plots are a static measure and summarise performance (relative to a comparator) over a fixed period of time. –Lack a dynamic element –Weight recent and distant results equally

Adding time – CUSUM Number of tx Cumulative sum O-E 01jan200401jan200501jan200601jan200701jan200801jan2009 Tx date Twoway CUSUM for a transplant centre

Removing credit for good deeds

Do we need to do more?

Why KPIs? Mortality is an insensitive and late indicators of problems –Hopefully rare –Outcome of complex series of events Incompletely ascertained –Important to monitor as best we can Key Process indicators –Simpler to understand, easier to address –Need to be valid and correctable (and related to meaningful outcomes)

KPI Project Dialysis KPI project commenced 2011 –At instigation of DNT committee 2 markers chosen – Peritonitis and HD access at first treatment –Deliberately limited to existing data collection NO additional data collected –Based on real time ANZDATA data collection

Variation in HD access

Variation in peritonitis rate 27

KPI reporting -- access Quarterly identified feedback to units

Peritonitis reporting

Where to from here? COMMUNICATE Improve data collection Improve access to results Enhance reporting –Add peritonitis rates –Access subdivided by late referral –Graphs etc etc Or is it all just too hard?

How do we view quality?

Centre reports -- SMR